Open innovation, open access platforms, and multi-party collaborations are generating creative business models for bringing to market new medicines that respond to unmet medical needs worldwide. Together, industry, research centers, non-profits, global agencies, venture capital community, consultants, and service providers are laying the foundations of a new collaborative biopharma ecosystem to translate early innovation into meaningful therapeutics. This session’s panel discussion will examine recent developments for accelerating drug innovation and raising the prospects for success.

Key Takeaways:

  • Explain why drug innovation translation to meaningful therapeutics requires collaboration among many business, research, translational, and financial partners
  • Foster and promote collaborative environments across the biopharma sector
  • Demonstrate success of collaborative models in drug innovation with examples

Ability Level: Advanced

Session ID: 2502

myBIO Chatter
Educational Topics